Prosecution Insights
Last updated: April 19, 2026

Gc Cell Corporation

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18285636 CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND NATURAL KILLER CELLS COMPRISING THE SAME CHATTIN, AMY MARIE 1643 Non-Final OA Oct 04, 2023
18285634 CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-CD19 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND NATURAL KILLER CELLS COMPRISING THE SAME CHATTIN, AMY MARIE 1643 Non-Final OA Oct 04, 2023
18268167 EXPANDED AND STIMULATED NATURAL KILLER CELLS PAULUS, ERIN VIRGINIA 1631 Non-Final OA Jun 16, 2023
17040661 METHOD FOR PRODUCING NATURAL KILLER CELLS GONZALES, JOSEPHINE MARIA 1631 Final Rejection Jan 14, 2021

Managing Gc Cell Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month